A general analytical platform and strategy in search for illegal drugs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 100, Issue , 2014, Pages 215-229

  Johansson, Monika ^a,b   Fransson, Dick ^a   Rundlöf, Torgny ^a   Huynh, Ngoc Hang ^a   Arvidsson, Torbjörn ^a,b  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Accurate mass determination; LC QTOF MS; Quantitative NMR (qNMR); Screening; Suspected illegal medicines

Indexed keywords

ACETONITRILE; AMFEBUTAMONE; AMPHETAMINE; BETAMETHASONE ACETATE; BIMATOPROST; BISACODYL; BUMETANIDE; CAFFEINE; CETILISTAT; CODEINE; DEXAMETHASONE; EPHEDRINE; ETHINYLESTRADIOL; EVODIAMINE; FENFLURAMINE; FLUOXETINE; FORMIC ACID; FORSKOLIN; FUROSEMIDE; HORDENINE; ILLICIT DRUG; MORPHINE; NIMESULIDE; PHENOLPHTHALEIN; PHENTERMINE; RIMONABANT; SIBUTRAMINE; SILDENAFIL; TETRAHYDROLIPSTATIN; TRIAMCINOLONE ACETONIDE; COUNTERFEIT DRUG; DRUG DOSAGE FORM; METHANOL; SOLVENT; ANALGESIC AGENT; CORTICOSTEROID; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN DERIVATIVE;

ACCURACY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DISPERSION; DRUG CAPSULE; DRUG POTENCY; EXTRACTION; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MATRIX SOLID PHASE DISPERSION; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; TABLET; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DATABASE; DRUG DOSAGE FORM; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES; QUALITY CONTROL; REPRODUCIBILITY; STANDARDS; TANDEM MASS SPECTROMETRY; DATA BASE; DRUG SCREENING; ELUTION; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TIME OF FLIGHT MASS SPECTROMETRY; MEASUREMENT ACCURACY; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; WEIGHT REDUCTION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUNTERFEIT DRUGS; DATABASES, PHARMACEUTICAL; DOSAGE FORMS; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SOLVENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84906685197     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.07.026     Document Type: Article

References (33)

1. WHO Fact Sheets no. 275 Medicines: Spurious/Falsely-Labelled/Falsified/Counterfeit (SFFC) Medicines 2012, http://www.who.int/mediacentre/factsheets/fs275/en/index.html (accessed 13.01.14).
2. Interpol Pangea VII Media Release 2014, http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Operations/Operation-Pangea (accessed 15.06.14).
3. Council of Europe, HealthCare The MEDICRIME Convention, Background and Scope 2014, http://www.edqm.eu/en/the-medicrime-convention-1470.html (accessed 13.01.14).
4. Council of Europe, Control of Medicines, General European OMCL Network, (accessed 10.02.14). http://www.edqm.eu/en/General-european-OMCL-network-46.html.
5. Martino R., Malet-Martino M., Gilard V., Balayssac S. Counterfeit drugs: analytical techniques for their identification. Anal. Bioanal. Chem. 2010, 398:77-92.
6. Holzgrabe U., Malet-Martino M. Analytical challenges in drug counterfeiting and falsification - the NMR approach. J. Pharm. Biomed. Anal. 2011, 55:679-687.
7. Deconinck E., Sacré P.-Y., Courselle P., De Beer J.O. Chemometrics and chromatographic fingerprints to discriminate and classify counterfeit medicines containing PDE-5 inhibitors. Talanta 2012, 100:123-133.
8. Rebiere H., Guinot P., Civade C., Bonnet P.-A., Nicolas A. Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2012, 29(2):161-171.
9. Poplawska M., Blazewicz A., Bukowinska K., Fijalek Z. Application of high-performance liquid chromatography with charged aerosol detection for universal quantitation of undeclared phosphodiesterase-5 inhibitors in herbal dietary supplements. J. Pharm. Biomed. Anal. 2013, 84:232-243.
10. Venhuis B.J., de Kaste D. Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. J. Pharm. Biomed. Anal. 2012, 69:196-208.
11. Wiest J., Schollmayer C., Gresser G., Holzgrabe U. Identification and quantitation of the ingredients in a counterfeit Vietnamese herbal medicine against rheumatic diseases. J. Pharm. Biomed. Anal. 2014, 97:24-28.
12. Desmedt B., Van Hoeck E., Rogiers V., Courselle P., De Beer J.O., De Paepe K., Deconinck E. Characterization of suspected illegal skin whitening cosmetics. J. Pharm. Biomed. Anal. 2014, 90:85-91.
13. Bekiroglu S., Myrberg O., Östman K., Ek M., Arvidsson T., Rundlöf T., Hakkarainen B. Validation of a quantitative NMR method for suspected counterfeit products exemplified on determination of benzethonium chloride in grapefruit seed extracts. J. Pharm. Biomed. Anal. 2008, 47:958-961.
14. 1H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52:645-651.
15. 1H NMR spectroscopy of pharmaceuticals. J. Pharm. Biomed. Anal. 2014, 93:111-117.
16. (accessed 10.02.14). http://www.lakemedelsverket.se/olagliga.
17. Sanchez-Prado L., Lamas J.P., Alvarez-Rivera G., Lores M., Garcia-Jares C., Llompart M. Determination of suspected fragrance allergens in cosmetics by matrix solid-phase dispersion gas chromatography-mass spectrometry analysis. J. Chromatogr. A 2011, 1218:5055-5062.
18. Clarke's analysis of drugs and poisons, (accessed 10.02.14). http://www.medicinescomplete.com/.
19. Guale F., Shahreza S., Walterscheid J.P., Chen H.-H., Arndt C., Kel Mozayani A.T. Validation of LC-TOF-MS screening for drugs, metabolites and collateral compounds in forensic toxicology specimens. J. Anal. Toxicol. 2013, 37(1):17-24.
20. 31P NMR spectroscopy. Applications to analytical standards and agricultural chemicals. Anal. Chem. 1998, 70:4921-4928.
21. Malz F., Jancke H. Validation of quantitative NMR. J. Pharm. Biomed. Anal. 2005, 38:813-823.
22. Commission Decision (2002/657/EC) Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Commun. 2002, L221:8. (Brussels, Belgium).
23. Amini A., Barclay V., Rundlöf T., Jönsson S., Karlsson A., Arvidsson T. Determination of ephedrine, pseudoephedrine and caffeine in a dietary product by capillary electrophoresis. Chromatographia 2006, 63:143-148.
24. New Frontiers in the quality of medicines, workshop: building a partnership for the investigation of counterfeit medicines. EDQM International Conference 2007, 8-10. http://www.edqm.eu/medias/fichiers/Building_a_partnership_for_investigation_of_counterfeit_medicines.pdf (accessed 04.03.14).
25. (accessed 15.01.14). http://www.lakemedelsverket.se/Alla-nyheter/NYHETER-2009/Allvarliga-leverbiverkningar-kopplas-till-kosttillskottet-Fortodol/.
26. Tormod Å. A New Screening Method for Anti-Inflammatory and Analgesic Drug Substances - Development of a LC-MS Method for Screening of Drug Substances in Suspected Illegal Products 2009, (Master Thesis), Division of Analytical Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University.
27. Li L., Low M.-Y., Aliwarga F., Teo J., Ge X.-W., Zeng Y., Bloodworth B.C., Koh H.-L. Isolation and identification of hydroxythiohomosildenafil in herbal dietary supplements sold as sexual performance enhancement products. Food Addit. Contam. 2009, 26(2):145-151.
28. 2α-isopropyl ester to latanoprost: a review of the development of Xalatan, the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 2001, 42(6):1134-1145.
29. Alm A., Grierson I., Shields M.B. Side effects associated with prostaglandin analog therapy. Surv. Ophthalmol. 2008, 53(Suppl. 1):S93-S105.
30. Peplinski L.S., Smith K.A. Deepening of lid sulcus from topical bimatoprost therapy. Optom. Vis. Sci. 2004, 81(8):574-577.
31. Pharmaceutical Ingredients in One Out of Three Eyelash Serums 2013, http://www.lakemedelsverket.se/english/All-news/NYHETER-2013/Pharmaceutical-ingredients-in-one-out-of-three-eyelash-serums/ (accessed 23.01.14).
32. McEwen I., Elmsjö A., Lehnström A., Hakkarainen B., Johansson M. Screening of counterfeit corticosteroid in creams and ointments by NMR spectroscopy. J. Pharm. Biomed. Anal. 2012, 70:245-250.
33. Grudin A. An Analytical Method to Identify and Quantify Glucocorticoids in Creams and Ointments Based on Matrix Solid Phase Dispersion and UPLC-MS/MS 2012, (Master Thesis), Division of Analytical Pharmaceutical Chemistry, Department of Medicinal Chemistry, Uppsala University.